giredestrant
selective ER degrader (SERD) + full antagonist oral (30 mg QD), Ph. III for ER+, HER2- BC from profiling >4k cmpds for desired MoA Journal of Medicinal Chemistry Genentech, San Francisco, US
Molecules of the Month - July 2021
Molecules of the Month
- giredestrant
- pemigatinib
- ceralasertib (AZD6738)
- VIP152 (BAY 1251152)
- TAK-653
- TAK-071
- TAK-041
- TAK-906
- KZR-616
- "compound 10"
- PTC596
- "compound 10"
- GSK852
- compound 59